At least nine drugmakers have modified their contract pharmacy restrictions in Arkansas after the state said it planned to enforce its 340B law following an appeals court decision. An additional nine manufacturers loosened restrictions prior to the court decision.

Four More Drugmakers to End 340B Contract Pharmacy Restrictions in Arkansas Following Appeals Court Decision

Bristol Myers Squibb (BMS), Amgen, and Bayer became the latest drugmakers to formally exempt Arkansas providers from their 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report